Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aquammunist is a proprietary cosmeceutical technology developed by Cantabria Labs (Industrial Farmacéutica Cantabria) for topical application. It is derived from a unique natural spring in La Solía, Cantabria, where freshwater and saltwater from the Cantabrian Sea meet, resulting in a mineral-rich composition containing specific microalgae. The technology is designed to address the needs of reactive and hypersensitive skin by soothing irritation, protecting the skin's barrier function, and reducing overall skin reactivity. Aquammunist serves as the core ingredient in the SKIN RESIST product line, which specifically targets skin aging in individuals with sensitive or reactive skin profiles. Its efficacy in maintaining skin homeostasis and controlling hypersensitivity has been documented in scientific research published in high-impact journals.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Aquammunist.